Methylprednisolone and Brilinta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Methylprednisolone (methylprednisolone) and Brilinta (ticagrelor). Common drug interactions include dizziness among females and blood pressure diastolic increased among males.

The phase IV clinical study analyzes what interactions people have when they take Methylprednisolone and Brilinta. It is created by eHealthMe based on reports of 39 people who take the same drugs from the FDA, and is updated regularly.

What is Methylprednisolone?

Methylprednisolone has active ingredients of methylprednisolone. It is often used in inflammation. eHealthMe is studying from 59,645 Methylprednisolone users. Check the latest studies of Methylprednisolone.

What is Brilinta?

Brilinta has active ingredients of ticagrelor. It is often used in stent. eHealthMe is studying from 22,469 Brilinta users. Check the latest studies of Brilinta.

On Jul, 18, 2026

39 people who take Methylprednisolone and Brilinta together, and have interactions are studied.

Methylprednisolone and Brilinta drug interactions.

What are the common drug interactions of Methylprednisolone and Brilinta, by gender? *:

female:

Dizziness
Vision blurred
Chronic kidney disease
Renal failure (kidney dysfunction)
Fatigue (feeling of tiredness)
Breast cancer metastatic
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Nephrogenic anaemia (anaemia due to kidney disease)
Pain
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)

male:

Blood pressure diastolic increased
Blood pressure systolic increased
Heart rate decreased
Heart rate increased
Nasopharyngitis (inflammation of the nasopharynx)
Nausea (feeling of having an urge to vomit)
Oropharyngeal pain
Pneumonia
Sinus congestion (blockage of sinus)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)

What are the common drug interactions of Methylprednisolone and Brilinta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dizziness
Vision blurred
Chronic kidney disease
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Dysstasia (difficulty in standing)
Emotional distress
Gait disturbance
Nephrogenic anaemia (anaemia due to kidney disease)
Pain

50-59:

Breast cancer metastatic
Chronic kidney disease
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Renal failure (kidney dysfunction)
Blood pressure diastolic increased
Blood pressure systolic increased
Body temperature decreased
Chest pain
Dizziness
Heart rate decreased

60+:

Chronic kidney disease
Dyspnoea (difficult or laboured respiration)
Fluid retention (an abnormal accumulation of fluid in the blood)
Gallbladder disorder
Haemoglobin decreased
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection)
Joint swelling
Pain
Pneumonia
Red blood cell sedimentation rate increased

What are the existing conditions these people have? *

Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 12 people, 30.77%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 9 people, 23.08%
Pain: 7 people, 17.95%
High Blood Cholesterol: 7 people, 17.95%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 17.95%
Infection: 4 people, 10.26%
High Blood Pressure: 4 people, 10.26%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 2 people, 5.13%
Oedema (fluid collection in tissue): 2 people, 5.13%
Nausea (feeling of having an urge to vomit): 2 people, 5.13%

* Approximation only. Some reports may have incomplete information.

Do you take Methylprednisolone and Brilinta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously